Improving pain management for older cancer survivors
Centralized Pain Management In Older Adult Cancer Survivors
This study is looking to improve pain management for older adults who have survived cancer by understanding the different types of pain they experience and how to best tailor medications for them, so healthcare providers can make better treatment choices.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10991839 on NIH RePORTER |
What this research studies
This research aims to enhance the management of centralized pain in older adults who have survived cancer. It focuses on understanding how different types of pain—neuropathic, nociceptive, and nociplastic—affect this population and how medications can be tailored to their specific needs. By examining provider decision-making and medication use patterns, the study seeks to develop a clinical decision support system that can guide healthcare providers in choosing the most appropriate treatments. The research employs a mixed methods approach to gather comprehensive data on the experiences of older adult cancer survivors with centralized pain.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 65 and above who have survived cancer and experience centralized pain.
Not a fit: Patients who are younger than 65 or do not have a history of cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain management strategies for older cancer survivors, improving their quality of life.
How similar studies have performed: Previous research has shown that Mechanistic-Based Pain Therapy can improve patient outcomes in other populations, suggesting potential success for this approach in older cancer survivors.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Smith, Michael a — University of Michigan at Ann Arbor
- Study coordinator: Smith, Michael a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.